257 related articles for article (PubMed ID: 29556906)
1. Long noncoding RNAs in the mTOR signaling network: biomarkers and therapeutic targets.
Huang T; Wang M; Huang B; Chang A; Liu F; Zhang Y; Jiang B
Apoptosis; 2018 Jun; 23(5-6):255-264. PubMed ID: 29556906
[TBL] [Abstract][Full Text] [Related]
2. Emerging Role of mTOR Signaling-Related miRNAs in Cardiovascular Diseases.
Samidurai A; Kukreja RC; Das A
Oxid Med Cell Longev; 2018; 2018():6141902. PubMed ID: 30305865
[TBL] [Abstract][Full Text] [Related]
3. Regulation of mTOR signaling by long non-coding RNA.
Aboudehen K
Biochim Biophys Acta Gene Regul Mech; 2020 Apr; 1863(4):194449. PubMed ID: 31751821
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA (lncRNA) Growth Arrest Specific 5 (GAS5) Suppresses Esophageal Squamous Cell Carcinoma Cell Proliferation and Migration by Inactivating Phosphatidylinositol 3-kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway.
Wang G; Sun J; Zhao H; Li H
Med Sci Monit; 2018 Oct; 24():7689-7696. PubMed ID: 30368517
[TBL] [Abstract][Full Text] [Related]
5. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract][Full Text] [Related]
6. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.
Polivka J; Janku F
Pharmacol Ther; 2014 May; 142(2):164-75. PubMed ID: 24333502
[TBL] [Abstract][Full Text] [Related]
7. The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era.
Liu ST; Hui G; Mathis C; Chamie K; Pantuck AJ; Drakaki A
Clin Genitourin Cancer; 2018 Apr; 16(2):e269-e276. PubMed ID: 29199023
[TBL] [Abstract][Full Text] [Related]
8. Long non‑coding RNA linc00239 promotes malignant behaviors and chemoresistance against doxorubicin partially via activation of the PI3K/Akt/mTOR pathway in acute myeloid leukaemia cells.
Yang Y; Dai W; Sun Y; Zhao Z
Oncol Rep; 2019 Apr; 41(4):2311-2320. PubMed ID: 30720129
[TBL] [Abstract][Full Text] [Related]
9. Cross-talk between non-coding RNAs and PI3K/AKT/mTOR pathway in colorectal cancer.
Moafian Z; Maghrouni A; Soltani A; Hashemy SI
Mol Biol Rep; 2021 May; 48(5):4797-4811. PubMed ID: 34057685
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of lncRNA OGFRP1 induces autophagy and growth inhibition by AKT/mTOR signaling pathway in HCAECs.
Zhang X; Liu J; Gu Y; Sun C; Qu F
Cell Biol Int; 2019 Feb; 43(2):158-166. PubMed ID: 30536541
[TBL] [Abstract][Full Text] [Related]
11. Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer.
Evangelisti C; Chiarini F; Paganelli F; Marmiroli S; Martelli AM
Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118635. PubMed ID: 31884070
[TBL] [Abstract][Full Text] [Related]
12. Correlation between telomerase and mTOR pathway in cancer stem cells.
Dogan F; Biray Avci C
Gene; 2018 Jan; 641():235-239. PubMed ID: 29074462
[TBL] [Abstract][Full Text] [Related]
13. The mTOR pathway in lung cancer and implications for therapy and biomarker analysis.
Ekman S; Wynes MW; Hirsch FR
J Thorac Oncol; 2012 Jun; 7(6):947-53. PubMed ID: 22588151
[TBL] [Abstract][Full Text] [Related]
14. LncRNAs and neoplasia.
Isin M; Dalay N
Clin Chim Acta; 2015 Apr; 444():280-8. PubMed ID: 25748036
[TBL] [Abstract][Full Text] [Related]
15. Role of cytoplasmic lncRNAs in regulating cancer signaling pathways.
Fu PF; Zheng X; Fan X; Lin AF
J Zhejiang Univ Sci B; 2019 Jan.; 20(1):1-8. PubMed ID: 30614225
[TBL] [Abstract][Full Text] [Related]
16. HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway.
Pan S; Liu Y; Liu Q; Xiao Y; Liu B; Ren X; Qi X; Zhou H; Zeng C; Jia L
Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):750-760. PubMed ID: 30742932
[TBL] [Abstract][Full Text] [Related]
17. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer.
Li W; Zhai L; Wang H; Liu C; Zhang J; Chen W; Wei Q
Oncotarget; 2016 May; 7(19):27778-86. PubMed ID: 27034004
[TBL] [Abstract][Full Text] [Related]
19. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism.
Ellis BC; Graham LD; Molloy PL
Biochim Biophys Acta; 2014 Feb; 1843(2):372-86. PubMed ID: 24184209
[TBL] [Abstract][Full Text] [Related]
20. PI3K/Akt/mTOR pathway inhibitors in cancer: a perspective on clinical progress.
Wu P; Hu YZ
Curr Med Chem; 2010; 17(35):4326-41. PubMed ID: 20939811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
